"The acquisition, which includes a 136,000 square foot building situated on 10 acres of industrial land, facilitates the Company's phased expansion initiatives related to cannabis production and extracts processing. The Board of Directors has approved the initial buildout of approximately 70,000 square feet. This phase of construction will bring Organigram's annual production capacity to approximately 16,000 kg of flower, and approximately 6,400 kg of fan and sweet leaf. The planned expansion also includes a state of the art 20,000 square foot commercial scale oils and extracts manufacturing facility that is engineered and designed in collaboration with our partners in Colorado, TGS International LLC. This phase of our fully funded expansion will commence immediately and is expected to be completed and operational by the fall of 2017.
The remaining square footage of the acquired building is being subleased by OrganiGram and provides the Company with approximately $777,000 in lease payments and shared operating costs on an annual basis. This allows the Company to keep its overhead low and to pursue the expansion initiatives in a more cost effective manner."
Note:
This Buy Transaction will not be reported on this Next Quarterly Report on the 25th of October so, it will insure 3 straight Quarters of profitability for OrganiGram
It doesn't get any better than this Folks.
One smart CEO and one smart Financial Advisor = XIB
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.